|
Volumn , Issue , 2011, Pages 337-340
|
A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOANTIBODY;
HLA ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
ARTICLE;
BLOOD;
DESENSITIZATION;
DRUG EFFECT;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TEST;
HUMAN;
IMMUNOLOGICAL MONITORING;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
MALE;
PROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
TIME;
TRANSPLANTATION TOLERANCE;
TREATMENT OUTCOME;
UNITED STATES;
DESENSITIZATION, IMMUNOLOGIC;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
MALE;
MONITORING, IMMUNOLOGIC;
NORTH CAROLINA;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
TRANSPLANTATION TOLERANCE;
TREATMENT OUTCOME;
|
EID: 84864080105
PISSN: 08909016
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|